Paull Robert Bradley 4
4 · Kala Pharmaceuticals, Inc. · Filed Jun 14, 2018
Insider Transaction Report
Form 4
Paull Robert Bradley
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2018-06-12+12,960→ 12,960 totalExercise: $13.73Exp: 2028-06-11→ Common Stock (12,960 underlying)
Footnotes (1)
- [F1]This option was granted on June 12, 2018 and vests in equal monthly installments until the one-year anniversary of the date of grant and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.